Women's health xxxxx paid for xxxxx & prioritized
Women’s health, paid for & prioritized
Because today's payment system keeps research and care from reaching most women.
The Problem Is Payment
Women’s health is chronically underpaid, underinvested, and undervalued, leaving a $1 trillion market opportunity stranded. Seen is building the AI payment infrastructure needed to unlock what’s been missing: evidence-based payment to fuel scale, innovation, and sustainable growth.
25-75%
80%
2-4x






Breaking the AI Invisibility Cycle
Compounding the financial problem is a data problem: AI systems are learning from incomplete data that keeps women's health underpaid and under-prioritized.
80%
8 in 10
50%
Research Momentum Meets Payment Bottlenecks
Funding for women’s health research is finally rising and long overdue. But without modern payment infrastructure to match these advances, breakthroughs stall before they reach patients.
95%
17 years
66%



Their Stories

Seven year diagnostic delay for endometriosis. Symptoms dismissed as ‘normal.’ Finally, surgery. But the surgeon knows the truth: it’s a money losing disease to the healthcare system. 11
Though endometriosis affects 1 in 10 women, providers get paid identically regardless of complexity or outcomes-- a meticulous excision with an 80% success rate or a quick ablation with a 40-60% recurrence rate. Combined with reimbursement rates 40-60% below comparable treatments, this dual failure penalizes evidence-based care and perpetuates deprioritized services and persistent undervaluation.

Screened positive for postpartum depression. Prescribed medication. Denied by insurance. Weeks waiting for appeal while symptoms worsen.12
Told to try this cheaper one first. It doesn’t work. Symptoms worsen during the critical intervention window. Only 22% of women screening positive receive mental health treatment. Step-therapy requirements force mothers to fail cheaper medications before accessing proven care—during the weeks when depression deepens and suicide risk climbs.

Hot flashes. Brain fog. Work performance declines. She seeks treatment - her insurance covers some HRT. She’s among the lucky 26%.13
Though menopause affects all women at midlife—51% of the population—coverage remains a zip code lottery. New plans like HelloMeno (launching January 2026 in 11 states) offer $0 copays. But 74% of women still lack full coverage, 60% pay out-of-pocket, and nearly 50% face insurance denials. Their untreated symptoms cost the U.S. $1.8 billion annually in lost work—progress is accelerating, but access remains deeply inequitable.
Let’s Talk
This site focuses on the problem and opportunity by design. If you’d like to hear more about how we’re building toward solutions and who we’re working with, get in touch.
If you have experience navigating payment for women’s health—whether as a patient, clinician, payer, employer, or innovator—and want to share a story, explore partnership, or stay connected as we build, get in touch.
